NCT07030439 2025-06-22
A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State
Impact Therapeutics, Inc.
Phase 1 Completed
Impact Therapeutics, Inc.
Guangzhou University of Traditional Chinese Medicine
Peking University
Asan Medical Center
National Taiwan University Hospital
Chiba University
Seoul National University Hospital